Hypercholesterolemia and lipid-lowering therapy in children and adolescents with type 1 diabetes - Do we implement current guidelines?
Authors:
- Jantje WeiskornJWJantje Weiskorn
- Marianne BeckerMBMarianne Becker
- Johanna HammersenJHJohanna Hammersen
- Susanne Bechtold-Dalla PozzaSPSusanne Bechtold-Dalla Pozza
- Elke Müller-RoßbergEMElke Müller-Roßberg
- Martin HolderMHMartin Holder
- Marie-Anne BurckhardtMBMarie-Anne Burckhardt
- Reinhard Walter HollRHReinhard Walter Holl
Preprint
- 17 March 2026
- preprint
- Published by American Diabetes Association
Abstract
ObjectiveWe investigated the prevalence of elevated LDL-cholesterol in youths with type 1 diabetes (T1D), contributing factors, the frequency of lipid-lowering medication (LLM) and the achievement of target values.Research Design and MethodsA cross-sectional analysis based on data from the DPV registry from 2013-2023. Inclusion criteria were T1D, age 2.6, >3.4 and >4.1mmol/l were defined. Application of national and international treatment guidelines were examined. Descriptive analyses and linear and logistic regression models were implemented using SAS 9.4.Results55,028 included participants. 9.7% and 2.3% had LDL >3.4mmol/l and >4.1mmol/l respectively. HbA1c (ß=1,142.7, p=0.001), female sex (ß=861.5, p70th percentile (ß=520.1, p3.4 and 87.0% with LDL >4.1mmol/l were not treated. Estimated odds ratios for the use of LLM were 19.13 [95% CI 15.4-23.7] for LDL >4.1mmol/l, 3.1 [1.82-5.41] for age 12-18 years, 2.31 [1.9-2.1] for diabetes duration 5-10 years, 1.8 [1.5-2.1] for BMI>70th percentile, 1.3 [1.0-1.6] for HbA1c >9%, and 1.18 [1.0-1.4] for female sex. However, only 15.7% of the treated patients (n=707) reached the target of 3.4mmol/l. ConclusionWe found a high prevalence of LDL hypercholesterolemia. The use of LLM despite treatment indication was low, treatment targets were mostly not achieved either due to underdosing or non-adherence to LLM. These findings confirm that dyslipidemia remains an underestimated cardiovascular risk factor in pediatric diabetology.Keywords
All Related Versions
- Published version: Diabetes Care, 49 (5), 755.